Lunsumio

Indicated For

follicular lymphoma

About This Medication

# Genentech Patient Foundation Patient Guide: How to Get Lunsumio (mosunetuzumab) at Low or No Cost Lunsumio (mosunetuzumab) is a prescription medicine used to treat certain adults with relapsed or refractory follicular lymphoma who have received at least two prior systemic therapies. The **Genentech Patient Foundation** offers this medication at no cost to eligible patients who are uninsured, lack coverage for the drug, or meet specific income criteria, helping reduce financial barriers to treatment. ## About Lunsumio (mosunetuzumab) **Lunsumio** is a bispecific CD20xCD3 monoclonal antibody administered via intravenous infusion. It works by engaging T-cells to target and kill cancer cells expressing CD20, a protein found on B-cells in follicular lymphoma. This therapy is typically given in cycles: a step-up dosing in cycle 1 to reduce infusion-related reactions, followed by fixed doses in subsequent cycles. Treatment continues until disease progression or unacceptable toxicity. Common side effects include infusion-related reactions, fatigue, nausea, and infections—discuss risks with your doctor. Always follow your healthcare provider's instructions for safe use. ## Who Qualifies for the Genentech Patient Foundation? The program supports U.S. residents treated by U.S.-licensed physicians, with no citizenship requirement. Eligibility focuses on financial need and insurance status: - **Uninsured patients** or those **without coverage for the Genentech medicine** (like Lunsumio). - **Insured patients** must first pursue other assistance options and confirm the medicine is unaffordable due to high out-of-pocket costs. - Income limits: Generally, household income under **$150,000 per year** (some exceptions apply), adjusted for household size. **Important**: Insured patients should exhaust commercial coverage, appeals, or other aid before applying. Medicare patients may qualify if they lack coverage for Lunsumio or face unaffordable costs exceeding 7.5% of yearly income. ## Income Eligibility Breakdown Specific Federal Poverty Level (FPL) percentages aren't detailed, but the program targets households with income under $150,000. Household size is assessed during application. Here's a simplified table based on program guidelines: | Household Size | Approximate Max Income | Notes | |---------------|------------------------|-------| | 1 | Under $150,000 | Adjusted for exceptions; exact verification required | | 2 | Under $150,000 | Includes all household members | | 3 | Under $150,000 | Income proof may be requested | | 4+ | Under $150,000 | Contact specialist for details | *Table derived from program forms; final eligibility determined by foundation review. Call (888) 941-3331 for personalized assessment.* ## Insurance Requirements - **Uninsured**: Automatically considered if income-eligible. - **Insured without coverage for Lunsumio**: Eligible after confirming no coverage. - **Insured with coverage**: Must prove unaffordable (e.g., out-of-pocket max >7.5% of income). Try copay assistance, appeals, or prior authorizations first. No support for administrative errors or step edits without physician appeal (one level allowed in some cases). - **Medicare/Medicaid**: Eligible if no coverage for the drug or costs are unaffordable; plan doesn't penalize applying. Your prescriber attests to medical necessity and insurance details on the form. ## Step-by-Step Application Process Applying is straightforward and free. Both you and your doctor must complete forms. Here's how: 1. **Contact a Foundation Specialist**: Call **(888) 941-3331** (Mon-Fri, 6 a.m.–5 p.m. PT) to discuss eligibility and start. 2. **Complete Patient Consent Form**: Fill out online (English/Spanish at gene.com/patients/enrollment), print/sign page 3, or have your doctor's office assist. Include household size, income, insurance status (uninsured, insured no coverage, or unaffordable). 3. **Doctor Completes Prescriber Foundation Form**: Page 4 (or page 2 in some versions). Includes diagnosis (e.g., follicular lymphoma), prescription details, shipment option (home/practice), refills (up to 1 year), and attestation. 4. **Submit Forms**: - **Fax**: (833) 999-4363 (both forms). - **Text**: Photo to (650) 877-1111 (Patient Consent). - **Online**: eSubmit via GenentechPatientFoundation.com or My Patient Solutions. Both forms required—no action until received. 5. **Wait for Review**: Processed within **5 business days**. You'll and your doctor contacted by phone about outcome/next steps. ## Timeline and Delivery - **Processing**: 5 business days after complete forms received. - **Notification**: Phone call to patient and prescriber. - **Delivery**: Free shipment to your home, doctor's office, or treatment site via foundation pharmacy. Options: upfront shipments or product replacement (doctor uses inventory, foundation replenishes). - **Refills**: Up to 1 year; prescriber requests as needed within guidelines. ## Alternatives if Denied - **Appeal internally**: Discuss with Foundation Specialist; provide more info if needed. - **Other Genentech support**: Genentech Access Solutions at (866) 422-2377 or Genentech-Access.com for copay help, free trial, or bridging. - **External options**: Patient Access Network (PAN), HealthWell Foundation, or state programs. Check NeedyMeds.org or RxAssist.org. - **Appeal insurance denial**: File with your plan (proof not needed for initial application). - **Clinical trials**: Ask your doctor about Lunsumio studies. ## Disclaimer This guide is for informational purposes based on publicly available Genentech Patient Foundation details as of latest updates. Eligibility, processes, and income thresholds can change—always verify with the foundation at (888) 941-3331 or GenentechPatientFoundation.com. Not medical/financial advice; consult your doctor and advisor. Genentech not liable for application errors. Program for U.S. residents only.

Program information last verified: March 25, 2026